Chapter
1. Introduction
|
1.1. Market Definition
|
1.2. Research Scope
|
1.2.1. Markets Covered
|
1.2.2. Years Considered for
Study
|
|
Chapter 2. Research
Methodology
|
2.1. Research Sources
|
2.1.1. Primary
|
2.1.2. Secondary
|
2.2. Market Size Estimation
|
|
Chapter
3. Executive Summary
|
3.1. Summary Snapshot Market Size
and Forecast, 2018-2029
|
3.2. Sclerotherapy Market Share by
Agent, 2021 vs 2029 (USD Million)
|
3.3. Sclerotherapy Market Share by Type,
2021 vs 2029 (USD Million)
|
3.4. Sclerotherapy Market Share by ,
2021 vs 2029 (USD Million)
|
3.5. Sclerotherapy Market Share by
Region, 2021 vs 2029 (USD Million)
|
|
Chapter 4.
Key Insights
|
|
Chapter 5.
Sclerotherapy Market Segmentation & Impact Analysis
|
5.1. Sclerotherapy Market Indicators
Analysis
|
5.1.1. Market Drivers
Analysis
|
5.1.1.1. Increasing Geriatric
Population with Incidence of Varicose Veins
|
5.1.1.2. Increase of
Technological Advancements Pertaining to Venous Diseases
|
5.1.1.3. Increasing
Demand of Less Invasive Procedures
|
5.1.2. Market Restraint
Analysis
|
5.1.2.1. Side
effects and Risks associated with Sclerotherapy treatment
|
5.2. Regulatory Analysis
|
5.2.1. North America
|
5.2.1.1. U.S.
|
5.2.1.2. Canada
|
5.2.2. Europe
|
5.2.3. Asia Pacific
|
5.2.3.1. India
|
5.2.3.2. Japan
|
5.2.3.3. China
|
5.3. Technological Insights
|
5.4. COVID-19 Impact analysis on
Sclerotherapy Market
|
5.5. Porter’s Five Forces Analysis
|
5.5.1. Bargaining Power of
Buyers/Consumers
|
5.5.2. Bargaining Power of
Suppliers
|
5.5.3. Threat of New Entrants
|
5.5.4. Threat of Substitute
Products
|
5.5.5. Intensity of Competitive
Rivalry
|
5.6. Competitive Metric Space Analysis
|
|
Chapter
6. Sclerotherapy Market, By Agent (Market Size and Forecast by Value -
USD Million, 2018 - 2029)
|
6.1. Sclerotherapy Market, By Agent
(Market Size and Forecast by Value - USD Million, 2021 & 2029)
|
6.1.1. Detergents
|
6.1.1.1. Detergents Market Estimates and Forecast,
2019-2029 (USD Million)
|
6.1.1.2. Detergents Market Estimates and Forecast,
By Region, 2019-2029 (USD Million)
|
6.1.2. Chemical Irritants
|
6.1.2.1. Chemical
Irritants Market Estimates and Forecast, 2019-2029 (USD Million)
|
6.1.2.2. Chemical
Irritants Market Estimates and Forecast, By Region, 2019-2029 (USD Million)
|
6.1.3. Osmotic Agents
|
6.1.3.1. Osmotic
Agents Market Estimates and Forecast, 2019-2029 (USD Million)
|
6.1.3.2. Osmotic
Agents Market Estimates and Forecast, By Region, 2019-2029 (USD Million)
|
|
Chapter
7. Sclerotherapy Market, By Type (Market Size and Forecast by Value -
USD Million, 2018 - 2029)
|
7.1. Sclerotherapy Market, By Type
(Market Size and Forecast by Value - USD Million, 2021 & 2029)
|
7.1.1. Ultrasound Sclerotherapy
|
7.1.1.1. Ultrasound Sclerotherapy Market Estimates
and Forecast, 2019-2029 (USD Million)
|
7.1.1.2. Ultrasound Sclerotherapy Market Estimates
and Forecast, By Region, 2019-2029 (USD Million)
|
7.1.2. Liquid Sclerotherapy
|
7.1.2.1. Liquid Sclerotherapy Market Estimates and
Forecast, 2019-2029 (USD Million)
|
7.1.2.2. Liquid Sclerotherapy Market Estimates and
Forecast, By Region, 2019-2029 (USD Million)
|
7.1.3. Foam Sclerotherapy
|
7.1.3.1. Foam
Sclerotherapy Market Estimates and Forecast, 2019-2029 (USD Million)
|
7.1.3.2. Foam
Sclerotherapy Market Estimates and Forecast, By Region, 2019-2029 (USD
Million)
|
|
Chapter 8.
Sclerotherapy Market, By Region (Market Size and Forecast by Value - USD
Million, 2018 - 2029)
|
8.1. Sclerotherapy Market, By Region
(Market Size and Forecast by Value - USD Million, 2021 & 2029)
|
8.2. North America
|
8.2.1. North America
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.2.2. North America
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.2.3. North America
Sclerotherapy Market, By Country, 2018-2029 (USD Million)
|
8.2.4. U.S.
|
8.2.4.1. U.S.
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.2.4.2. U.S.
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.2.5. Canada
|
8.2.5.1. Canada
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.2.5.2. Canada
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
|
8.3. Europe
|
8.3.1. Europe Sclerotherapy
Market, By Agent, 2018-2029 (USD Million)
|
8.3.2. Europe Sclerotherapy
Market, By Type, 2018-2029 (USD Million)
|
8.3.3. Europe Sclerotherapy
Market, By Country, 2018-2029 (USD Million)
|
8.3.4. Germany
|
8.3.4.1. Germany
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.3.4.2. Germany
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.3.5. U.K.
|
8.3.5.1. U.K. Sclerotherapy Market, By
Agent, 2018-2029 (USD Million)
|
8.3.5.2. U.K.
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.3.6. France
|
8.3.6.1. France Sclerotherapy
Market, By Agent, 2018-2029 (USD Million)
|
8.3.6.2. France
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.3.7. Spain
|
8.3.7.1. Spain
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.3.7.2. Spain
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.3.8. Italy
|
8.3.8.1. Italy
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.3.8.2. Italy
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.3.9. Rest of Europe
|
8.3.9.1. Rest of
Europe Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.3.9.2. Rest of
Europe Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
|
8.4. Asia Pacific
|
8.4.1. Asia Pacific
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.4.2. Asia Pacific
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.4.3. Asia Pacific
Sclerotherapy Market, By Country, 2018-2029 (USD Million)
|
8.4.4. India
|
8.4.4.1. India Sclerotherapy
Market, By Agent, 2018-2029 (USD Million)
|
8.4.4.2. India
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.4.5. Japan
|
8.4.5.1. Japan
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.4.5.2. Japan
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.4.6. China
|
8.4.6.1. China
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.4.6.2. China
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.4.7. South Korea
|
8.4.7.1. South
Korea Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.4.7.2. South
Korea Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.4.8. Australia
|
8.4.8.1.
Australia Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.4.8.2.
Australia Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.4.9. Rest of Asia Pacific
|
8.4.9.1. Rest of
Asia Pacific Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.4.9.2. Rest of
Asia Pacific Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
|
8.5. Middle East & Africa
|
8.5.1. Middle East & Africa
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.5.2. Middle East &
AfricaSclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.5.3. Middle East & Africa
Sclerotherapy Market, By Country, 2018-2029 (USD Million)
|
8.5.4. UAE
|
8.5.4.1. UAE
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.5.4.2. UAE
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.5.5. Saudi Arabia
|
8.5.5.1. Saudi Arabia Sclerotherapy Market,
By Agent, 2018-2029 (USD Million)
|
8.5.5.2. Saudi
Arabia Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.5.6. South Africa
|
8.5.6.1. South
Africa Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.5.6.2. South
Africa Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.5.7. Rest of Middle East
& Africa
|
8.5.7.1. Rest of
Middle East & Africa Sclerotherapy Market, By Agent, 2018-2029 (USD
Million)
|
8.5.7.2. Rest of
Middle East & Africa Sclerotherapy Market, By Type, 2018-2029 (USD
Million)
|
|
8.6. Latin America
|
8.6.1. Latin America
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.6.2. Latin America
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.6.3. Latin America
Sclerotherapy Market, By Country, 2018-2029 (USD Million)
|
8.6.4. Brazil
|
8.6.4.1. Brazil
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.6.4.2. Brazil
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.6.5. Mexico
|
8.6.5.1. Mexico
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.6.5.2. Mexico
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.6.6. Argentina
|
8.6.6.1.
Argentina Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.6.6.2.
Argentina Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
8.6.7. Rest of Latin America
|
8.6.7.1. Rest of
Latin America Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
8.6.7.2. Rest of
Latin America Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
|
Chapter
9. Competitive Landscape
|
9.1. Market Revenue Share by
Manufacturers
|
9.2. Competitor’s Positioning
|
9.3. Strategy Benchmarking
|
9.3.1. Partnership &
Agreement
|
9.3.2. New Product Development
|
9.3.3. Mergers &
Acquisitions
|
9.3.4. Investment &
Expansion
|
9.4. Vendor Landscape
|
9.4.1. Distributors
|
9.4.2. North America
|
9.4.3. Europe
|
9.4.4. Asia Pacific
|
9.4.5. Middle East &
Africa
|
9.4.6. Latin America
|
9.5. Zettabyte Analytics Insights for
Competitive Landscape
|
|
Chapter
10. Company Profiles
|
10.1. BTG
|
10.1.1. Partnership &
Agreement
|
10.1.2. New Product
Development
|
10.1.3. Mergers &
Acquisitions
|
10.1.4. Investment &
Expansion
|
10.2. Kreussler
|
10.2.1. Partnership &
Agreement
|
10.2.2. New Product
Development
|
10.2.3. Mergers &
Acquisitions
|
10.2.4. Investment &
Expansion
|
10.3. LGM Pharma
|
10.3.1. Partnership &
Agreement
|
10.3.2. New Product
Development
|
10.3.3. Mergers &
Acquisitions
|
10.3.4. Investment &
Expansion
|
10.4. Troikaa
|
10.4.1. Partnership &
Agreement
|
10.4.2. New Product
Development
|
10.4.3. Mergers &
Acquisitions
|
10.4.4. Investment &
Expansion
|
10.5. ChanganTianyu group
|
10.5.1. Partnership &
Agreement
|
10.5.2. New Product
Development
|
10.5.3. Mergers &
Acquisitions
|
10.5.4. Investment &
Expansion
|
10.6. Bioniche Pharma Group Ltd.
|
10.6.1. Partnership &
Agreement
|
10.6.2. New Product
Development
|
10.6.3. Mergers &
Acquisitions
|
10.6.4. Investment &
Expansion
|
10.7. Omega Pharmaceuticals
|
10.7.1. Partnership &
Agreement
|
10.7.2. New Product
Development
|
10.7.3. Mergers &
Acquisitions
|
10.7.4. Investment &
Expansion
|
10.8. Merz Pharma
|
10.8.1. Partnership &
Agreement
|
10.8.2. New Product
Development
|
10.8.3. Mergers &
Acquisitions
|
10.8.4. Investment &
Expansion
|
10.9. Endo-Flex
|
10.9.1. Partnership &
Agreement
|
10.9.2. New Product
Development
|
10.9.3. Mergers &
Acquisitions
|
10.9.4. Investment &
Expansion
|
|
List of
Tables
|
Sclerotherapy
Market, By Agent (Market Size and Forecast by Value - USD Million, 2021 &
2029)
|
Detergents
Market Estimates and Forecast, 2019-2029 (USD Million)
|
Detergents
Market Estimates and Forecast, By Region, 2019-2029 (USD Million)
|
Chemical
Irritants Market Estimates and Forecast, 2019-2029 (USD Million)
|
Chemical
Irritants Market Estimates and Forecast, By Region, 2019-2029 (USD Million)
|
Osmotic
Agents Market Estimates and Forecast, 2019-2029 (USD Million)
|
Osmotic
Agents Market Estimates and Forecast, By Region, 2019-2029 (USD Million)
|
Sclerotherapy
Market, By Type (Market Size and Forecast by Value - USD Million, 2021 &
2029)
|
Ultrasound
Sclerotherapy Market Estimates and Forecast, 2019-2029 (USD Million)
|
Ultrasound
Sclerotherapy Market Estimates and Forecast, By Region, 2019-2029 (USD
Million)
|
Liquid
Sclerotherapy Market Estimates and Forecast, 2019-2029 (USD Million)
|
Liquid
Sclerotherapy Market Estimates and Forecast, By Region, 2019-2029 (USD
Million)
|
Foam
Sclerotherapy Market Estimates and Forecast, 2019-2029 (USD Million)
|
Foam
Sclerotherapy Market Estimates and Forecast, By Region, 2019-2029 (USD
Million)
|
Market Estimates and Forecast, 2019-2029
(USD Million)
|
Market Estimates and Forecast, By Region,
2019-2029 (USD Million)
|
North America
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
North America
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
North America
Sclerotherapy Market, By Country, 2018-2029 (USD Million)
|
U.S.
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
U.S.
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
Canada
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
Canada
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
Europe
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
Europe
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
Europe
Sclerotherapy Market, By Country, 2018-2029 (USD Million)
|
Germany
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
Germany
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
U.K.
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
U.K.
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
France
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
France
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
Spain
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
Spain
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
Italy
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
Italy
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
Rest of
Europe Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
Rest of
Europe Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
Rest of
Europe Sclerotherapy Market, By , 2018-2029 (USD Million)
|
Asia Pacific
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
Asia Pacific
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
Asia Pacific
Sclerotherapy Market, By , 2018-2029 (USD Million)
|
Asia Pacific
Sclerotherapy Market, By Country, 2018-2029 (USD Million)
|
India
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
India
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
Japan
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
Japan
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
China
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
China
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
South Korea
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
South Korea
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
Australia
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
Australia
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
Rest of Asia
Pacific Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
Rest of Asia
Pacific Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
Middle East
& Africa Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
Middle East
& AfricaSclerotherapy Market, By Type, 2018-2029 (USD Million)
|
Middle East
& Africa Sclerotherapy Market, By Country, 2018-2029 (USD Million)
|
UAE
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
UAE
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
Saudi Arabia
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
Saudi Arabia
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
South Africa
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
South Africa
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
Rest of
Middle East & Africa Sclerotherapy Market, By Agent, 2018-2029 (USD
Million)
|
Rest of
Middle East & Africa Sclerotherapy Market, By Type, 2018-2029 (USD
Million)
|
Latin America
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
Latin America
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
Latin America
Sclerotherapy Market, By Country, 2018-2029 (USD Million)
|
Brazil
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
Brazil
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
Mexico
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
Mexico
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
Argentina
Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
Argentina
Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
Rest of Latin
America Sclerotherapy Market, By Agent, 2018-2029 (USD Million)
|
Rest of Latin
America Sclerotherapy Market, By Type, 2018-2029 (USD Million)
|
Product
Launch & Development in The Sclerotherapy Market, 2018-2021
|
Investment
& Expansion in The Sclerotherapy Market, 2018-2021
|
Partnership
& Collaboration in The Sclerotherapy Market, 2018-2021
|
Merger &
Acquisition in The Sclerotherapy Market, 2018-2021
|
|
List of
Figures
|
Research
Methodology
|
Summary
Snapshot Market Size and Forecast, USD Million, 2021 & 2029
|
Global Sclerotherapy
Market Segmentation & Impact Analysis
|
Regulatory
Analysis
|
COVID-19
Impact analysis on Sclerotherapy Market
|
Market
Revenue Share by Manufacturers
|
Sclerotherapy
Market, By Agent (Market Size and Forecast by Value - USD Million, 2021 &
2029)
|
Sclerotherapy
Market, By Type (Market Size and Forecast by Value - USD Million, 2021 &
2029)
|
Sclerotherapy
Market, By Region (Market Size and Forecast by Value - USD Million, 2021
& 2029)
|